wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37200511-B14B8909-4E45-4A67-A385-C883A7A84897
Q37200511-B14B8909-4E45-4A67-A385-C883A7A84897
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37200511-B14B8909-4E45-4A67-A385-C883A7A84897
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
P2860
Q37200511-B14B8909-4E45-4A67-A385-C883A7A84897
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37200511-B14B8909-4E45-4A67-A385-C883A7A84897
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
049bd619a339b4672b4122ab83d42cae8c6a0e87
P2860
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.